Literature DB >> 22626945

Clonazepam quiets tinnitus: a randomised crossover study with Ginkgo biloba.

Seon-Sook Han1, Eui-Cheol Nam, Jun Yeon Won, Kang Uk Lee, Wanjoo Chun, Hyun Kyung Choi, Robert Aaron Levine.   

Abstract

OBJECTIVE: To assess the effect of Ginkgo biloba and clonazepam, a γ-aminobutyric acid (GABA)-receptor agonist, upon tinnitus.
METHODS: This was an open-label, randomised, crossover study. 27 men and 11 women (aged 16-80 (mean 58)) with tinnitus for more than 2 months were enrolled. Participants were randomised to either clonazepam or G biloba for the first 3 weeks. For the next 2 weeks of washout no medication was taken. For the final 3 weeks, subjects were given the other drug. The initial dose of clonazepam and G biloba was one tablet daily (clonazepam 0.5 mg; G biloba 40 mg). Subjects were instructed to increase the dose by one tablet every 3 days to a maximum of four tablets daily until they perceived a satisfactory decrease in tinnitus loudness or intolerable side effects. Tinnitus was assessed with pitch and loudness matching, tinnitus handicap inventory, and visual analogue scales of loudness, duration and annoyance.
RESULTS: Comparing before and after each drug, clonazepam significantly improved tinnitus loudness (74% of subjects), duration (63%), annoyance (79%), and tinnitus handicap inventory score (61%), whereas the G biloba showed no significant differences on any of these measures.
CONCLUSION: Clonazepam is effective in treating tinnitus; G biloba is ineffective.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22626945     DOI: 10.1136/jnnp-2012-302273

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Tinnitus Management in Lateral Skull Base Lesions.

Authors:  Juan San Juan; Gregory J Basura
Journal:  J Neurol Surg B Skull Base       Date:  2018-11-30

Review 2.  Evidence and evidence gaps in tinnitus therapy.

Authors:  Gerhard Hesse
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

3.  [Decompensated chronic tinnitus and high-dose benzodiazepine dependence. Between Scylla and Charybdis].

Authors:  U Bonnet
Journal:  Nervenarzt       Date:  2014-07       Impact factor: 1.214

Review 4.  Maladaptive plasticity in tinnitus--triggers, mechanisms and treatment.

Authors:  Susan E Shore; Larry E Roberts; Berthold Langguth
Journal:  Nat Rev Neurol       Date:  2016-02-12       Impact factor: 42.937

Review 5.  A multidisciplinary systematic review of the treatment for chronic idiopathic tinnitus.

Authors:  Hans-Peter Zenner; Wolfgang Delb; Birgit Kröner-Herwig; Burkhard Jäger; Ingrid Peroz; Gerhard Hesse; Birgit Mazurek; Gerhard Goebel; Christian Gerloff; Regina Trollmann; Eberhard Biesinger; Harald Seidler; Berthold Langguth
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-19       Impact factor: 2.503

6.  Protective effects of Ginkgo biloba extract EGb 761 against noise trauma-induced hearing loss and tinnitus development.

Authors:  Konstantin Tziridis; Sabine Korn; Sönke Ahlf; Holger Schulze
Journal:  Neural Plast       Date:  2014-06-17       Impact factor: 3.599

Review 7.  The Management and Outcomes of Pharmacological Treatments for Tinnitus.

Authors:  Devon Beebe Palumbo; Kathleen Joos; Dirk De Ridder; Sven Vanneste
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 8.  Sensorineural Tinnitus: Its Pathology and Probable Therapies.

Authors:  Aage R Møller
Journal:  Int J Otolaryngol       Date:  2016-02-08

9.  South Korean geriatrics on Beers Criteria medications at risk of adverse drug events.

Authors:  Grace Juyun Kim; Kye Hwa Lee; Ju Han Kim
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

10.  Human Auditory Cortex Neurochemistry Reflects the Presence and Severity of Tinnitus.

Authors:  William Sedley; Jehill Parikh; Richard A E Edden; Valerie Tait; Andrew Blamire; Timothy D Griffiths
Journal:  J Neurosci       Date:  2015-11-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.